BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 25151728)

  • 1. [The in vitro anti-atherosclerotic activity of compound IMB-1680].
    Feng TT; Li YZ; Li N; Liu C; Wang X; Xu YN; Si SY
    Yao Xue Xue Bao; 2014 May; 49(5):602-7. PubMed ID: 25151728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two antagonists of the scavenger receptor CD36 using a high-throughput screening model.
    Xu Y; Wang J; Bao Y; Jiang W; Zuo L; Song D; Hong B; Si S
    Anal Biochem; 2010 May; 400(2):207-12. PubMed ID: 20152792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synthesis and structure-activity relationship of 13-hexylberberine analogues as CD36 antagonists].
    Li YH; Wang L; Hong B; Xu YN; Si SY; Jiang JD; Song DQ
    Yao Xue Xue Bao; 2010 Sep; 45(9):1128-33. PubMed ID: 21351569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake.
    Amézaga N; Sanjurjo L; Julve J; Aran G; Pérez-Cabezas B; Bastos-Amador P; Armengol C; Vilella R; Escolà-Gil JC; Blanco-Vaca F; Borràs FE; Valledor AF; Sarrias MR
    J Leukoc Biol; 2014 Mar; 95(3):509-20. PubMed ID: 24295828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of scavenger receptor class A type I/II is not important for smooth muscle foam cell formation.
    Luechtenborg B; Hofnagel O; Weissen-Plenz G; Severs NJ; Robenek H
    Eur J Cell Biol; 2008 Feb; 87(2):91-9. PubMed ID: 17980455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
    Lin CS; Lin FY; Ho LJ; Tsai CS; Cheng SM; Wu WL; Huang CY; Lian CH; Yang SP; Lai JH
    Cardiovasc Res; 2012 Aug; 95(3):346-55. PubMed ID: 22687273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lycopene on the induction of foam cell formation by modified LDL.
    Napolitano M; De Pascale C; Wheeler-Jones C; Botham KM; Bravo E
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1820-7. PubMed ID: 17911344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
    Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW
    J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner.
    Zhao Z; de Beer MC; Cai L; Asmis R; de Beer FC; de Villiers WJ; van der Westhuyzen DR
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):168-73. PubMed ID: 15514202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxidized low density lipoprotein induces macrophage endoplasmic reticulum stress via CD36.].
    Yao ST; Sang H; Yang NN; Kang L; Tian H; Zhang Y; Song GH; Qin SC
    Sheng Li Xue Bao; 2010 Oct; 62(5):433-40. PubMed ID: 20945046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA.
    Dai XY; Cai Y; Sun W; Ding Y; Wang W; Kong W; Tang C; Zhu Y; Xu MJ; Wang X
    Cardiovasc Res; 2014 Feb; 101(2):297-305. PubMed ID: 24253523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ionizing radiation induces macrophage foam cell formation and aggregation through JNK-dependent activation of CD36 scavenger receptors.
    Katayama I; Hotokezaka Y; Matsuyama T; Sumi T; Nakamura T
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):835-46. PubMed ID: 18262097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
    Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
    Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation.
    Rahaman SO; Lennon DJ; Febbraio M; Podrez EA; Hazen SL; Silverstein RL
    Cell Metab; 2006 Sep; 4(3):211-21. PubMed ID: 16950138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducer and activator of transcription 1 is required for optimal foam cell formation and atherosclerotic lesion development.
    Agrawal S; Febbraio M; Podrez E; Cathcart MK; Stark GR; Chisolm GM
    Circulation; 2007 Jun; 115(23):2939-47. PubMed ID: 17533179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.
    Podrez EA; Febbraio M; Sheibani N; Schmitt D; Silverstein RL; Hajjar DP; Cohen PA; Frazier WA; Hoff HF; Hazen SL
    J Clin Invest; 2000 Apr; 105(8):1095-108. PubMed ID: 10772654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophages.
    Chiurchiù V; Izzi V; D'Aquilio F; Vismara D; Carotenuto F; Catanzaro G; Maccarrone M
    Peptides; 2011 Jan; 32(1):80-5. PubMed ID: 20932867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages.
    Lian TW; Wang L; Lo YH; Huang IJ; Wu MJ
    Biochim Biophys Acta; 2008 Oct; 1781(10):601-9. PubMed ID: 18662803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages.
    Okutsu R; Yoshikawa T; Nagasawa M; Hirose Y; Takase H; Mitani K; Okada K; Miyakoda G; Yabuuchi Y
    Atherosclerosis; 2009 Jun; 204(2):405-11. PubMed ID: 19108834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolin Acts as a Scavenger Receptor for Acetylated Low-Density Lipoprotein on Macrophages.
    Miki Y; Tachibana Y; Ohminato Y; Fujiwara Y
    Biol Pharm Bull; 2015; 38(9):1420-4. PubMed ID: 26328500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.